Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IMAT - ultrafast tomography for coronary artery disease -- Ignore unavailable to you. Want to Upgrade?

To: Bruce A. Brotnov who wrote (3606)	10/3/2000 2:15:32 PM
From: Harold Burgeson	Read Replies (2) \| Respond to of 3725

IMAT making a nice move on roughly double daily average volume yesterday and today. Increasing sales and revenues are probably helping and publicity from Oprah's scan might be helping a little. Public awareness of the scan capability is growing. I had a two month wait to get a scan in Austin, TX. Unfortunately many doctors regard the scan as only a screening tool when in fact the Imatron scanner is also capable of performing electron beam angiograms at no risk and a fraction of the cost of conventional angiograms. Full body scans will make the annual physical much more complete. Some day....soon I hope.. the market will recognize the potential in sales and service fees.